Effectiveness of statins in patients with stroke due to cervical artery dissection: A preliminary study
Bruno Kusznir Vitturi1, Rubens José Gagliardi1
1Department of Neurology, Santa Casa de São Paulo School of Medical Sciences, Dr. Cesário Motta Júnior Street 112, 01221-020 São Paulo, Brazil.
Insights
Statin therapy may improve functional outcomes for stroke patients with cervical artery dissection (CAD). However, statins did not prevent stroke recurrence or major cardiovascular events in this specific patient group.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Clinical Research
Background:
- Statin therapy is crucial for secondary stroke prevention.
- Clinical evidence for statin use in cervical artery dissection (CAD)-related ischemic stroke is lacking.
- This study addresses the impact of statins on neurological outcomes in CAD stroke patients.
Purpose of the Study:
- To investigate the effect of statin therapy on neurological outcomes in patients experiencing ischemic stroke secondary to CAD.
- To evaluate functional recovery, stroke recurrence, major cardiovascular events, and mortality in CAD stroke patients treated with varying statin regimens.
Main Methods:
- Prospective cohort study design.
- Inclusion of consecutive patients diagnosed with stroke due to CAD.
- Classification into non-statin, simvastatin 20mg, simvastatin 40mg, and high-potency statin groups.
- 2-year follow-up assessing functional outcome, stroke recurrence, major cardiovascular events, and mortality.
Main Results:
- Simvastatin 40mg use was linked to a significantly lower incidence of stroke recurrence.
- Patients treated with simvastatin 40mg or high-potency statins showed the best functional recovery.
- No significant reduction in stroke recurrence or major cardiovascular events was observed across all statin groups.
Conclusions:
- Statin therapy may enhance functional outcomes in select patients with CAD-related stroke.
- Current evidence does not support statins for preventing stroke recurrence or major cardiovascular events in this population.
Background:
Statin therapy has become one of the most important advances in stroke secondary prevention. Nevertheless, statin therapy in patients who present an ischemic stroke following cervical artery dissection (CAD) has not yet been supported by clinical evidence. This study aimed to investigate the effect of statins on neurological outcomes after a stroke due to CAD.
Methods:
We conducted a prospective cohort study including consecutive patients diagnosed with a stroke due to CAD. Subjects were classified into non-statin, simvastatin 20mg, simvastatin 40mg, and high-potency statin groups. After 2 years, the functional outcome, stroke recurrence, major cardiovascular events, and mortality were assessed.
Results:
Among the 54 patients included in our cohort, there were 16 (29.6%) patients without statins, 22 (40.7%) with simvastatin 20mg, 12 (22.2%) with simvastatin 40mg and 4 (7.5%) with high-potency statins. Using simvastatin 40mg was associated with a significantly lower incidence of stroke recurrence. Patients with simvastatin 40mg and high-potency statins presented the best functional recovery throughout the follow-up (p<.01).
Discussion:
The use of statins in patients with CAD-related stroke may improve functional outcomes in specific cases. Statins do not prevent stroke recurrence and major cardiovascular events in this type of stroke.
Related Concept Videos
01:26Atherosclerosis III: Management
01:23Atherosclerosis IV: Nursing Management
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:27Coronary Artery Disease V: Interprofessional Care
01:27Peripheral Artery Disease III: Interprofessional Care
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT